Design, synthesis and biological evaluation of novel diarylpyridine derivatives as tubulin polymerisation inhibitors

References

• Giodini A, Kallio MJ, Wall NR, Gorbsky GJ, Tognin S, Marchisio PC, Symons M, Altieri DC. Regulation of microtubule stability and mitotic progression by survivin. Cancer Res. 2002;62(9):2462–2467.
   PubMed Web of Science ®Google Scholar
• Lu Y, Chen J, Xiao M, Li W, Miller DD. An overview of tubulin inhibitors that interact with the colchicine binding site. Pharm Res. 2012;29(11):2943–2971.
   PubMed Web of Science ®Google Scholar
• Risinger AL, Giles FJ, Mooberry SL. Microtubule dynamics as a target in oncology. Cancer Treat Rev. 2009;35(3):255–261.
   PubMed Web of Science ®Google Scholar
• Wang C, Zhang Y, Xing D. Emerging tubulin inhibitors: a new hope for fungicides. J Agric Food Chem. 2021;69(38):11151–11153.
   PubMed Web of Science ®Google Scholar
• Wang C, Zhang Y, Wu Y, Xing D. Developments of CRBN-based PROTACs as potential therapeutic agents. Eur J Med Chem. 2021;225:113749.
   PubMed Web of Science ®Google Scholar
• Steinmetz MO, Prota AE. Microtubule-targeting agents: strategies to hijack the cytoskeleton. Trends Cell Biol. 2018;28(10):776–792.
   PubMed Web of Science ®Google Scholar
• Pettit GR, Singh SB, Hamel E, Lin CM, Alberts DS, Garcia-Kendall D. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4. Experientia. 1989;45(2):209–211.
   PubMedGoogle Scholar
• Pettit GR, Minardi MD, Rosenberg HJ, Hamel E, Bibby MC, Martin SW, Jung MK, Pettit RK, Cuthbertson TJ, Chapuis JC. Antineoplastic agents. 509: synthesis of fluorcombstatin phosphate and related 3-halostilbenes(1). J Nat Prod. 2005;68(10):1450–1458.
   PubMed Web of Science ®Google Scholar
• Pettit GR, Anderson CR, Herald DL, Jung MK, Lee DJ, Hamel E, Pettit RK. Antineoplastic agents. 487. Synthesis and biological evaluation of the antineoplastic agent 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene and derived amino acid amides. J Med Chem. 2003;46(4):525–531.
   PubMed Web of Science ®Google Scholar
• Cushman M, Nagarathnam D, Gopal D, Chakraborti AK, Lin CM, Hamel E. Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization. J Med Chem. 1991;34(8):2579–2588.
   PubMed Web of Science ®Google Scholar
• Liu R, Huang M, Zhang S, Li L, Li M, Sun J, Wu L, Guan Q, Zhang W. Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors. Eur J Med Chem. 2021;226:113826.
   PubMed Web of Science ®Google Scholar
• Xu Q, Bao K, Sun M, Xu J, Wang Y, Tian H, Zuo D, Guan Q, Wu Y, Zhang W. Design, synthesis and structure-activity relationship of 3,6-diaryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as novel tubulin inhibitors. Sci Rep. 2017;7(1):11997.
   PubMedGoogle Scholar
• Li L, Jiang S, Li X, Liu Y, Su J, Chen J. Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site. Eur J Med Chem. 2018;151:482–494.
   PubMed Web of Science ®Google Scholar
• Eissa IH, Dahab MA, Ibrahim MK, Alsaif NA, Alanazi AZ, Eissa SI, Mehany ABM, Beauchemin AM. Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site. Bioorg Chem. 2021;112:104965.
   PubMed Web of Science ®Google Scholar
• Hagras M, El Deeb MA, Elzahabi HSA, Elkaeed EB, Mehany ABM, Eissa IH. Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation. J Enzyme Inhib Med Chem. 2021;36(1):640–658.
   PubMed Web of Science ®Google Scholar
• Ling Y, Hao ZY, Liang D, Zhang CL, Liu YF, Wang Y. The expanding role of pyridine and dihydropyridine scaffolds in drug design. Drug Des Dev Ther. 2021;15:4289–4338.
   PubMed Web of Science ®Google Scholar
• Sigel E, Steinmann ME. Structure, function, and modulation of GABA(A) receptors. J Biol Chem. 2012;287(48):40224–40231.
   PubMed Web of Science ®Google Scholar
• Walan A, Bader JP, Classen M, Lamers CB, Piper DW, Rutgersson K, Eriksson S. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med. 1989;320(2):69–75.
   PubMed Web of Science ®Google Scholar
• Álvarez R, Aramburu L, Puebla P, Caballero E, González M, Vicente A, Medarde M, Peláez R. Pyridine based antitumour compounds acting at the colchicine site. Curr Med Chem. 2016;23(11):1100–1130.
   PubMed Web of Science ®Google Scholar
• He J, Zhang M, Tang L, Liu J, Zhong J, Wang W, Xu JP, Wang HT, Li XF, Zhou ZZ. Synthesis, biological evaluation, and molecular docking of arylpyridines as antiproliferative agent targeting tubulin. ACS Med Chem Lett. 2020;11(8):1611–1619.
   PubMed Web of Science ®Google Scholar
• Ashraf M, Shaik TB, Malik MS, Syed R, Mallipeddi PL, Vardhan M, Kamal A. Design and synthesis of cis-restricted benzimidazole and benzothiazole mimics of combretastatin A-4 as antimitotic agents with apoptosis inducing ability. Bioorg Med Chem Lett. 2016;26(18):4527–4535.
   PubMed Web of Science ®Google Scholar
• Zheng S, Zhong Q, Mottamal M, Zhang Q, Zhang C, Lemelle E, McFerrin H, Wang G. Design, synthesis, and biological evaluation of novel pyridine-bridged analogues of combretastatin-A4 as anticancer agents. J Med Chem. 2014;57(8):3369–3381.
   PubMed Web of Science ®Google Scholar
• Weiss R, Golisano T, Pale P, Mamane V. Insight into the modes of activation of pyridinium and bipyridinium salts in non-covalent organocatalysis. Adv Synth Catal. 2021;363(20):4779–4788.
   Web of Science ®Google Scholar
• Yang F, Jian XE, Diao PC, Huo XS, You WW, Zhao PL. Synthesis, and biological evaluation of 3,6-diaryl-[1,2,4]triazolo[4,3-a]pyridine analogues as new potent tubulin polymerization inhibitors. Eur J Med Chem. 2020;204:112625.
   PubMed Web of Science ®Google Scholar
• Li G, Wang Y, Li L, Ren Y, Deng X, Liu J, Wang W, Luo M, Liu S, Chen J. Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities. Eur J Med Chem. 2020;202:112519.
   PubMed Web of Science ®Google Scholar
• Wang C, Yang S, Du J, Ni J, Wu Y, Wang J, Guan Q, Zuo D, Bao K, Wu Y, et al. Synthesis and bioevaluation of diarylpyrazoles as antiproliferative agents. Eur J Med Chem. 2019;171:1–10.
   PubMed Web of Science ®Google Scholar
• Jadala C, Sathish M, Anchi P, Tokala R, Lakshmi UJ, Reddy VG, Shankaraiah N, Godugu C, Kamal A. Synthesis of combretastatin-A4 carboxamidest that mimic sulfonyl piperazines by a molecular hybridization approach: in vitro cytotoxicity evaluation and inhibition of tubulin polymerization. ChemMedChem. 2019;14(24):2052–2060.
   PubMed Web of Science ®Google Scholar
• Wang C, Li Y, Liu T, Wang Z, Zhang Y, Bao K, Wu Y, Guan Q, Zuo D, Zhang W. Design, synthesis and evaluation of antiproliferative and antitubulin activities of 5-methyl-4-aryl-3-(4-arylpiperazine-1-carbonyl)-4H-1,2,4-triazoles. Bioorg Chem. 2020;104:103909.
   PubMed Web of Science ®Google Scholar
• Kamal A, Srinivasa Reddy T, Polepalli S, Shalini N, Reddy VG, Subba Rao AV, Jain N, Shankaraiah N. Synthesis and biological evaluation of podophyllotoxin congeners as tubulin polymerization inhibitors. Bioorg Med Chem. 2014;22(19):5466–5475.
   PubMed Web of Science ®Google Scholar
• Kraus Y, Glas C, Melzer B, Gao L, Heise C, Preuße M, Ahlfeld J, Bracher F, Thorn-Seshold O. Isoquinoline-based biaryls as a robust scaffold for microtubule inhibitors. Eur J Med Chem. 2020;186:111865.
   PubMed Web of Science ®Google Scholar
• Sana S, Reddy VG, Srinivasa Reddy T, Tokala R, Kumar R, Bhargava SK, Shankaraiah N. Cinnamide derived pyrimidine-benzimidazole hybrids as tubulin inhibitors: synthesis, in silico and cell growth inhibition studies. Bioorg Chem. 2021;110:104765.
   PubMed Web of Science ®Google Scholar
• Tian C, Chen X, Zhang Z, Wang X, Liu J. Design and synthesis of (2-(phenylamino)thieno[3,2-d]pyrimidin-4-yl)(3,4,5-trimethoxyphenyl)methanone analogues as potent anti-tubulin polymerization agents. Eur J Med Chem. 2019;183:111679.
   PubMed Web of Science ®Google Scholar
• Sultana F, Reddy Bonam S, Reddy VG, Nayak VL, Akunuri R, Rani Routhu S, Alarifi A, Halmuthur MSK, Kamal A. Synthesis of benzo[d]imidazo[2,1-b]thiazole-chalcone conjugates as microtubule targeting and apoptosis inducing agents. Bioorg Chem. 2018;76:1–12.
   PubMed Web of Science ®Google Scholar
• Wang C, Li Y, Liu Z, Wang Z, Liu Z, Man S, Zhang Y, Bao K, Wu Y, Guan Q, et al. Design, synthesis and biological evaluation of 1-Aryl-5-(4-arylpiperazine-1-carbonyl)-1H-tetrazols as novel microtubule destabilizers. J Enzyme Inhib Med Chem. 2021;36(1):549–560.
   PubMed Web of Science ®Google Scholar